Klümper, N., Ralser, D. J., Ellinger, J., Roghmann, F., Albrecht, J., Below, E., . . . Eckstein, M. (2023). Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with Enfortumab vedotin resistance. Clinical cancer research, 29(8), . https://doi.org/10.1158/1078-0432.CCR-22-1764
Chicago-Zitierstil (17. Ausg.)Klümper, Niklas, et al. "Membranous NECTIN-4 Expression Frequently Decreases During Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance." Clinical Cancer Research 29, no. 8 (2023). https://doi.org/10.1158/1078-0432.CCR-22-1764.
MLA-Zitierstil (9. Ausg.)Klümper, Niklas, et al. "Membranous NECTIN-4 Expression Frequently Decreases During Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance." Clinical Cancer Research, vol. 29, no. 8, 2023, https://doi.org/10.1158/1078-0432.CCR-22-1764.